Archive: specialty drug management

  • May 16, 2024

    New Drug To Market Reviews

    New medications hit the market every year. Let’s evaluate how plan sponsors can evaluate impact with a new drug to market review.

  • May 10, 2024

    Humira Biosimilars Update: 2024

    Humira marks the first specialty drug with biosimilars, here is what you need to know about the most recent developments in this space.

  • April 25, 2024

    Understanding Specialty Medications

    Specialty medications represent a significant cost driver for pharmacy benefit plan sponsors. Examine several strategies to contain costs.

  • April 18, 2024

    The Value of Prior Authorizations

    Prior authorizations are a critical component of member care and pharmacy benefit cost control. Learn more about what PAs are and how they work.